Navigation Links
Life on Mars 'pregnancy test' successfully launched
Date:9/17/2007

Washington DC*-- Key components of a new approach to discover life on Mars were successfully launched into space Friday as part of a twelve-day, low-Earth orbit experiment to assess their survivability in the space radiation environmenta prelude future journeys to Mars.

The new approach is based on technology similar to that used in pregnancy test kits. The so-called immunoassays are embodied in the Life Marker Chip (LMC) experiment, which has the potential to detect trace levels of biomarkers in the Martian environment. Biomarkers are molecular fingerprints that indicate if life currently is, or ever was, present on Mars. The LMC experiment has been proposed for the European Space Agencys ExoMars rover mission, which is planned for launch in 2013. The LMC experiment is in the development phase and is led by an international consortium with researchers including Andrew Steele, a staff member of Carnegies Geophysical Laboratory in the United States, and scientists from the United Kingdom, The Netherlands, and Germany.

For the current mission, the consortium developed a tiny component, measuring only 1.5 inches x 1.6 inches x .5 inch ( 3.8 cm x 4.1 cm x 1.3 cm) and housing over 2000 samples, to test that the key molecular components to be used in the LMC technology can survive the rigors of space.

The experiment was launched from Baikonur Cosmodrome in Kazakhstan as part of the European Space Agencys BIOPAN-6 experiment platform. The LMC components will experience both weightlessness and the harsh space radiation environment while orbiting the Earth 180 times at an altitude of up to 190 miles (308 km) during the 11.8 day mission.

The BIOPAN-6 platform is mounted on the outside of an un-manned Russian FOTON spacecraft. Once in space the BIOPAN-6 platform will open to expose its contents directly to the space environment, testing both their resistance to space radiation and the space vacuum, before closing and returning to Earth on September 25th. The LMC components will then be taken back to laboratories in the United Kingdom and the United States to analyze the effect of the space flight.

The lead members of the consortium involved in the current mission are Deutsches Zentrum fr Luft- und Raumfahrt (DLR) (Germany), Cranfield University (UK), Carnegie Institution of Washington (USA) and University of Leicester (UK).

Dr. Andrew Steele from the Carnegie Institution of Washington (USA) and one of the initial experiment proposers said, in the USA we are currently flying related technology and components within the protected environment of the International Space Station (ISS) but this will be the first time that these types of materials will have flown unprotected in space in a manner similar to a flight to Mars.

Dr. Lutz Richter of DLR (Germany) and the principal investigator for the current experiment said, This experiment is the culmination of a number of years of hard work and ground based tests to prove the viability of the LMC technology.

Dr. David Cullen, from Cranfield University (UK) and who leads the scientific input into the current experiment, said, ?this will be our first space experiment to demonstrate our belief that immunoassay technology will have an important future role in space exploration and the search for life elsewhere in the Solar System.

Dr. Mark Sims from the University of Leicester (UK) and who heads the overall LMC project said, this mission will be an important stepping stone in our ultimate goal of putting a LMC experiment on the surface of Mars and using it to search for evidence of Life.


'/>"/>

Contact: Andrew Steele
a.steele@gl.ciw.edu
202-478-8974
Carnegie Institution
Source:Eurekalert

Related biology news :

1. Major new UNC-based drinking water study suggests pregnancy fears may be overstated
2. Any exposure to tobacco smoke during pregnancy is risky
3. Vitamin D deficiency widespread during pregnancy
4. Pregnancy drugs can affect grandkids
5. Major WHO study concludes calcium supplements can reduce complications during pregnancy
6. Study challenges myth that sex late in pregnancy hastens birth
7. Heavy smoking cuts womens chance of pregnancy -- even with donated oocytes
8. Pregnancy hormone key to repairing nerve cell damage
9. Experimental vaccine given during pregnancy reduces stillbirths from common virus
10. Procedure predicts embryos most likely to result in pregnancy
11. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)... Trends, opportunities and forecast in this market ... (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, vein ... use industry (government and law enforcement, commercial and retail, ... others), and by region ( North America ... Pacific , and the Rest of the World) ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... ... 21, 2017 , ... RMC Pharmaceutical Solutions, Inc. announces the ... to manage the new site. , Tim has 25 years of pharmaceutical experience, ... role as the Director of Manufacturing and Supplier Quality Assessment. This group ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... network RegMedNet has produced a Spotlight series on “Cell ... reviews and perspectives by leading experts on the unique regulatory challenges of stem ...
(Date:6/22/2017)... ... ... Charm Sciences, Inc. is pleased to announce that its Charm Amphenicol (AMPH) ... a screening test at dairies and farms for raw commingled cow milk. The test ... Lite system. These systems are a combination incubator and reader in one. , “The ...
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., ... to announce the issuance of a new patent covering ... hyperuricemia by the U.S. Patent and Trademark Office on ... winner of the Buzz of Bio award in 2014 ... akin to developing non-drug approaches to chronic disease. Renadyl™, ...
Breaking Biology Technology: